gbime0076mr-peripheral vascular devices market devices devices

Click here to load reader

Post on 25-Aug-2020

1 views

Category:

Documents

0 download

Embed Size (px)

TRANSCRIPT

  • Peripheral Vascular Devices Market to 2018 Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers

  • GBI Research Report Guidance

    GBIME0076MR / Published OCT 2012 Page 2

    © GBI Research. This is a licensed product and is not to be photocopied

    GBI Research Report Guidance

     Chapter three provides information on the market size for the historic period (2004-2011) and the forecast period (2011-2018). It also outlines market trends; dynamics, with comprehensive information on market drivers and restraints; and the competitive landscape.

     Chapter four discusses stent grafts, peripheral vascular stents, PTA balloons, peripheral embolic protection devices, IVCFs, synthetic surgical grafts, peripheral guidewires and PTA peripheral DEBs. The market size for the historic period (2004-2011) and the forecast period (2011-2018) is also discussed for each segment.

     Chapter five gives information on the market size for the historic period (2004-2011) and the forecast period (2011-2018) for the US, Canada, the UK, France, Germany, Italy, Spain, Japan, China, India, Australia and Brazil, with cross-country analysis. Market information for PTA peripheral DEBs has not been provided for the US, Canada and Japan, as they have not been approved in these countries.

     Chapter six gives profiles of the leading peripheral vascular device companies, outlining their products, features and benefits.

     Chapter seven focuses on the pipeline products for a range of segments. The key pipeline products are listed and discussed in detail alongside product approval and expected launch dates.

     Chapter eight discusses the deals that took place in the peripheral vascular devices industry between 2008 and 2011.

  • GBIME0076MR / Published OCT 2012

    Page 3 © GBI Research. This is a licensed product and is not to be photocopied

    Executive Summary

    Executive Summary

    The Peripheral Vascular Devices Market is Forecast to Exceed $XXbn by 2018

    The following figure gives the forecast revenues for the global peripheral vascular devices market.

    Peripheral Vascular Devices Market, Global, Revenues ($bn), 2011-2018

    2011 2018

    R ev

    en ue

    ($ bn

    )

    CAGR (2011-2018): XX%

    Source: GBI Research’s proprietary database, [accessed July 12, 2012]; interviews with marketing managers and other industry experts

    The global market is forecast to exceed $XX billion by 2018 having grown at a Compound Annual Growth Rate (CAGR) of XX% from 2011, driven by a growing patient pool due to the aging population, and other risk factors such as diabetes, obesity and lack of physical activity. Rising demand for endovascular procedures and the launch of new innovative devices such as Drug-Eluting Balloons (DEBs) will also drive market growth.

    Launch of Technologically Advanced Devices Such as Drug-eluting Balloons to Drive Future Adoption

    The launch of advanced products such as DEBs has resulted in growing demand for non-stent treatments for Peripheral Arterial Disease (PAD) and below-the-knee disorders in which stents cannot be used.

    Factors such as the shorter dual antiplatelet therapy regimen required by DEBs and the high risk of thrombosis associated with other treatment options are some of the favorable factors that will drive their adoption. DEBs are also able to overcome various issues associated with stents, such as high risk of restenosis, incomplete drug delivery and limited area coverage for drug delivery. These advantages are encouraging physicians to opt for DEBs for the treatment of Peripheral Vascular Diseases (PVDs), and the market is forecast to grow in the near future as a result.

    Due to the high risk of stent thrombosis, patients are prescribed anti-platelet therapy to prevent clot formation, making it unsuitable for elderly patients, pregnant women and those at high risk of bleeding. DEBs are preferable in this case as they require approximately three months of therapy in contrast to the 12 months required for Drug-Eluting Stents (DESs). This has increased demand for DEBs around the world.

    DEBs such as Paccocath from Bayer, SeQuent Please by B. Braun Melsungen, Advance PTX from Cook Medical, Dior from Eurocor and In.Pact Amphirion paclitaxel-eluting PTA balloon catheter from Medtronic have been launched and are available in Europe.

    The global peripheral vascular devices market is forecast to exceed $XX billion by 2018 having grown at a Compound Annual Growth Rate (CAGR) of XX% from 2011

  • GBIME0076MR / Published OCT 2012

    Page 6 © GBI Research. This is a licensed product and is not to be photocopied

    Table of Contents

    1 Table of Contents 1 Table of Contents................................................................................................................................. 6

    1.1 List of Tables............................................................................................................................. 9 1.2 List of Figures...........................................................................................................................11

    2 Introduction........................................................................................................................................12 3 Global Peripheral Vascular Devices Market - Market Characterization..................................................13

    3.1 Peripheral Vascular Devices Market, Revenue ($m), 2004-2011 ................................................13 3.2 Peripheral Vascular Devices Market, Revenue ($m), 2011-2018 ................................................15 3.3 Peripheral Vascular Devices Market, Key Company Shares (%), 2011.........................................17 3.4 Peripheral Vascular Devices Market, Key Trends.......................................................................18

    3.4.1 High Risk of Deep Vein Thrombosis Associated with Permanent Filters is Promoting the Use of Retrievable Inferior Vena Cava Filters ...........................................................................18

    3.4.2 Preference of Minimally Invasive Endovascular Procedures to Treat Peripheral Vascular Disease is a Global Trend..................................................................................................20

    3.5 Peripheral Vascular Devices: Market Dynamics.........................................................................21 3.5.1 Market Drivers.................................................................................................................21 3.5.2 Market Restraints ............................................................................................................25

    4 Global Peripheral Vascular Devices Market - Segment Analysis and Forecasts.......................................26 4.1 Stent Grafts Market, Global, Revenue ($m), 2004-2011 ............................................................26 4.2 Stent Grafts Market, Global, Revenue ($m), 2011-2018 ............................................................27 4.3 Peripheral Vascular Stents Market, Global, Revenue ($m), 2004-2011.......................................28 4.4 Peripheral Vascular Stents Market, Global, Revenue ($m), 2011-2018.......................................29 4.5 PTA Balloons Market, Global, Revenue ($m), 2004-2011...........................................................30 4.6 PTA Balloons Market, Global, Revenue ($m), 2011-2018...........................................................31 4.7 Peripheral Embolic Protection Devices Market, Global, Revenue ($m), 2004-2011.....................32 4.8 Peripheral Embolic Protection Devices Market, Global, Revenue ($m), 2011-2018.....................33 4.9 Inferior Vena Cava Filters Market, Global, Revenue ($m), 2004-2011 ........................................34 4.10 Inferior Vena Cava Filters Market, Global, Revenue ($m), 2011-2018 ........................................35 4.11 Synthetic Surgical Grafts Market, Global, Revenue ($m), 2004-2011..........................................36 4.12 Synthetic Surgical Grafts Market, Global, Revenue ($m), 2011-2018..........................................37 4.13 Peripheral Guidewires Market, Global, Revenue ($m), 2004-2011.............................................38 4.14 Peripheral Guidewires Market, Global, Revenue ($m), 2011-2018.............................................39 4.15 PTA Peripheral Drug-eluting Balloons Market, Global, Revenue ($m), 2004-2011 ......................40 4.16 PTA Peripheral Drug-eluting Balloons Market, Global, Revenue ($m), 2011-2018 ......................41

    5 Global Peripheral Vascular Devices Market - Country Analysis and Forecasts........................................42 5.1 Peripheral Vascular Devices Market: Cross-country Analysis .....................................................42 5.2 Historic and Forecast Revenue, by Country...............................................................................43

    5.2.1 Peripheral Vascular Devices Market, the US, Revenue ($m), 2004-2011 .............................43 5.2.2 Peripheral Vascular Devices Market, the US, Revenue ($m), 2011-2018 .............................45 5.2.3 Peripheral Vascular Devices Market, Canada, Revenue ($m), 2004-2011............................46 5.2.4 Peripheral Vascular Devices Market, Canada, Revenue ($m), 2011-2018............................48 5.2.5 Peripheral Vascular Devices Market, Germany, Revenue ($m), 2004-2011 ..

View more